Phase 2 Study of Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Lenalidomide (Primary) ; Cytarabine; Etoposide; Mitoxantrone
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 21 Jul 2017 Planned initiation date changed from 30 May 2017 to 31 Aug 2017.
- 10 May 2017 Planned initiation date changed from 30 Apr 2017 to 30 May 2017.
- 21 Apr 2017 New trial record